Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 31;33(1):28.
doi: 10.1038/s41533-023-00349-4.

Gold 2023: Highlights for primary care

Collaborators, Affiliations

Gold 2023: Highlights for primary care

Alvar Agustí et al. NPJ Prim Care Respir Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Range of lung function trajectories through the lifetime.
For further explanations, see text. Reproduced with permission from reference .
Fig. 2
Fig. 2. Proposed taxonomy (etiotypes) for COPD.
Reproduced with permission from www.goldcopd.org.
Fig. 3
Fig. 3. Initial pharmacological treatment.
Exacerbation history refers to exacerbations suffered the previous year. *: single inhaler therapy may be more convenient and effective than multiple inhalers. mMRC: modified Medical Research Dyspnoea Questionnaire. CAT: COPD Assessment Test. LAMA: long-acting anti-muscarinic antagonist; LABA: long-acting β2 receptor agonist; ICS: inhaled corticosteroid; eos: eosinophils. Reproduced with permission from www.goldcopd.org.
Fig. 4
Fig. 4. Follow-up pharmacological treatment.
*: single inhaler therapy may be more convenient and effective than multiple inhalers; **: Consider de-escalation of ICS if pneumonia or other considerable side-effects. In case of blood eos ≥300 cells/μl de-escalation is more likely to be associated with the development of exacerbations. Exacerbation history refers to exacerbations suffered the previous year. mMRC: modified Medical Research Dyspnea Questionnaire. CAT: COPD Assessment Test. LAMA: long-acting anti-muscarinic antagonist; LABA: long-acting β2 receptor agonist; ICS: inhaled corticosteroid; eos: eosinophils. Reproduced with permission from www.goldcopd.org.
Fig. 5
Fig. 5. Classification of the severity of COPD exacerbations.
Definition of abbreviations: VAS: visual analog scale; RR: respiratory rate; HR: heart rate; CRP: C-reactive protein. SaO2: arterial oxygen saturation; PaO2: arterial partial pressure of oxygen; ABG: arterial blood gases; ABG should show new onset/worsening hypercapnia or acidosis since a few patients may have chronic hypercapnia. Adapted from ref. . Reproduced with permission from www.goldcopd.org.

References

    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD), https://goldcopd.org/2023-gold-report-2/ (2023).
    1. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br. Med. J. 1977;1:1645–1648. doi: 10.1136/bmj.1.6077.1645. - DOI - PMC - PubMed
    1. Agustí A, Melén E, DeMeo DL, Breyer-Kohansal R, Faner R. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan. Lancet Respir. Med. 2022;10:512–524. doi: 10.1016/S2213-2600(21)00555-5. - DOI - PMC - PubMed
    1. Cho, M. H., Hobbs, B. D. & Silverman, E. K. Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder. Lancet Respiratory Med.10.1016/S2213-2600(21)00510-5 (2022). - PMC - PubMed
    1. Landis SH, et al. Continuing to confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013. Int. J. Chron. Obstruct. Pulmon. Dis. 2014;9:597–611. - PMC - PubMed

LinkOut - more resources